Chen Wan-Shan 4

What Happened

• Chen Wan-Shan, a director of Belite Bio, sold 1,100 American depositary shares (ADS) on April 9, 2026, at $180.43 per ADS for proceeds of $198,473. The transaction is reported as a sale (Form 4 code S) and was effected as an open-market or private sale.

Key Details

• Transaction date and price: 2026-04-09 — 1,100 ADS @ $180.43 each.
• Total proceeds: $198,473.
• Shares owned after the transaction: Not specified in the provided filing.
• Footnotes: Each ADS represents one ordinary share (F1). The sale was made pursuant to a Rule 10b5-1 trading plan adopted 12/23/2025 (F2).
• Filing timeliness: Report filed 2026-04-13, which is within the standard two business-day reporting window for a 4/9 trade (timely).

Context

• The sale was executed under a pre-arranged 10b5-1 plan, which typically schedules trades in advance and can indicate routine disposition rather than a new, discretionary view on the company. Sales do not necessarily signal negative insider sentiment; purchases are generally more informative for signaling.